Chapter/Section Purchase

1 Study Coverage
1.1 Premenstrual Syndrome Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Premenstrual Syndrome Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PH-80PMD
1.2.3 Estrogen
1.2.4 Progesterone
1.2.5 Others
1.3 Market by Application
1.3.1 Global Premenstrual Syndrome Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home Care
1.3.3 Hospital
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Premenstrual Syndrome Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Premenstrual Syndrome Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Premenstrual Syndrome Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Premenstrual Syndrome Medicine Sales by Region
2.4.1 Global Premenstrual Syndrome Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Premenstrual Syndrome Medicine by Region (2023-2028)
2.5 Global Premenstrual Syndrome Medicine Revenue by Region
2.5.1 Global Premenstrual Syndrome Medicine Revenue by Region (2017-2022)
2.5.2 Global Premenstrual Syndrome Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Premenstrual Syndrome Medicine Sales by Manufacturers
3.1.1 Global Top Premenstrual Syndrome Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Premenstrual Syndrome Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Premenstrual Syndrome Medicine in 2021
3.2 Global Premenstrual Syndrome Medicine Revenue by Manufacturers
3.2.1 Global Premenstrual Syndrome Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Premenstrual Syndrome Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Premenstrual Syndrome Medicine Revenue in 2021
3.3 Global Premenstrual Syndrome Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Premenstrual Syndrome Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Premenstrual Syndrome Medicine Sales by Type
4.1.1 Global Premenstrual Syndrome Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Premenstrual Syndrome Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Premenstrual Syndrome Medicine Sales Market Share by Type (2017-2028)
4.2 Global Premenstrual Syndrome Medicine Revenue by Type
4.2.1 Global Premenstrual Syndrome Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Premenstrual Syndrome Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Premenstrual Syndrome Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Premenstrual Syndrome Medicine Price by Type
4.3.1 Global Premenstrual Syndrome Medicine Price by Type (2017-2022)
4.3.2 Global Premenstrual Syndrome Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Premenstrual Syndrome Medicine Sales by Application
5.1.1 Global Premenstrual Syndrome Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Premenstrual Syndrome Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Premenstrual Syndrome Medicine Sales Market Share by Application (2017-2028)
5.2 Global Premenstrual Syndrome Medicine Revenue by Application
5.2.1 Global Premenstrual Syndrome Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Premenstrual Syndrome Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Premenstrual Syndrome Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Premenstrual Syndrome Medicine Price by Application
5.3.1 Global Premenstrual Syndrome Medicine Price by Application (2017-2022)
5.3.2 Global Premenstrual Syndrome Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Premenstrual Syndrome Medicine Market Size by Type
6.1.1 North America Premenstrual Syndrome Medicine Sales by Type (2017-2028)
6.1.2 North America Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
6.2 North America Premenstrual Syndrome Medicine Market Size by Application
6.2.1 North America Premenstrual Syndrome Medicine Sales by Application (2017-2028)
6.2.2 North America Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
6.3 North America Premenstrual Syndrome Medicine Market Size by Country
6.3.1 North America Premenstrual Syndrome Medicine Sales by Country (2017-2028)
6.3.2 North America Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Premenstrual Syndrome Medicine Market Size by Type
7.1.1 Europe Premenstrual Syndrome Medicine Sales by Type (2017-2028)
7.1.2 Europe Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
7.2 Europe Premenstrual Syndrome Medicine Market Size by Application
7.2.1 Europe Premenstrual Syndrome Medicine Sales by Application (2017-2028)
7.2.2 Europe Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
7.3 Europe Premenstrual Syndrome Medicine Market Size by Country
7.3.1 Europe Premenstrual Syndrome Medicine Sales by Country (2017-2028)
7.3.2 Europe Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Premenstrual Syndrome Medicine Market Size by Type
8.1.1 Asia Pacific Premenstrual Syndrome Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Premenstrual Syndrome Medicine Market Size by Application
8.2.1 Asia Pacific Premenstrual Syndrome Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Premenstrual Syndrome Medicine Market Size by Region
8.3.1 Asia Pacific Premenstrual Syndrome Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Premenstrual Syndrome Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Premenstrual Syndrome Medicine Market Size by Type
9.1.1 Latin America Premenstrual Syndrome Medicine Sales by Type (2017-2028)
9.1.2 Latin America Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
9.2 Latin America Premenstrual Syndrome Medicine Market Size by Application
9.2.1 Latin America Premenstrual Syndrome Medicine Sales by Application (2017-2028)
9.2.2 Latin America Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
9.3 Latin America Premenstrual Syndrome Medicine Market Size by Country
9.3.1 Latin America Premenstrual Syndrome Medicine Sales by Country (2017-2028)
9.3.2 Latin America Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Premenstrual Syndrome Medicine Market Size by Type
10.1.1 Middle East and Africa Premenstrual Syndrome Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Premenstrual Syndrome Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Premenstrual Syndrome Medicine Market Size by Application
10.2.1 Middle East and Africa Premenstrual Syndrome Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Premenstrual Syndrome Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Premenstrual Syndrome Medicine Market Size by Country
10.3.1 Middle East and Africa Premenstrual Syndrome Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Premenstrual Syndrome Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Asarina Pharma AB
11.1.1 Asarina Pharma AB Corporation Information
11.1.2 Asarina Pharma AB Overview
11.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Asarina Pharma AB Recent Developments
11.2 Pherin Pharmaceuticals Inc
11.2.1 Pherin Pharmaceuticals Inc Corporation Information
11.2.2 Pherin Pharmaceuticals Inc Overview
11.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pherin Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Premenstrual Syndrome Medicine Industry Chain Analysis
12.2 Premenstrual Syndrome Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Premenstrual Syndrome Medicine Production Mode & Process
12.4 Premenstrual Syndrome Medicine Sales and Marketing
12.4.1 Premenstrual Syndrome Medicine Sales Channels
12.4.2 Premenstrual Syndrome Medicine Distributors
12.5 Premenstrual Syndrome Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Premenstrual Syndrome Medicine Industry Trends
13.2 Premenstrual Syndrome Medicine Market Drivers
13.3 Premenstrual Syndrome Medicine Market Challenges
13.4 Premenstrual Syndrome Medicine Market Restraints
14 Key Findings in The Global Premenstrual Syndrome Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer